How Biocon Site Prevented FDA 'OAI' Finding From Derailing Biosimilars

 
• By Anju Ghangurde
  
Compliance
AN FDA EIR PROVIDES INSIGHTS INTO BIOCON'S COMPLIANCE JOURNEY
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Manufacturing

More from Compliance